Verona Pharma plc
VRNADelisted Oct 7, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001657312
Verona Pharma plc was delisted on Oct 7, 2025; its insiders filed their last Form 4 on Oct 8, 2025; 243 institutions reported holding it in 13F filings for Q3 2025, worth $8.57B in total; superinvestors Duquesne Family Office and Soros Fund Management held it.
13F holders, Q2 2023
Institutional positions in Verona Pharma plc as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 105
- +10 vs. Q1 2023
- Shares held
- 62.9M
- +2.48M (+4.1%) vs. Q1 2023
- Total value
- $1.33B
- +$121.2M (+10.0%) vs. Q1 2023
- New holders
- 21
- 30 more added
- Sold out
- 11
- 32 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VRNA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 1 | $359.0K |
| Q3 2025 | 243 | $8.57B |
| Q2 2025 | 292 | $7.18B |
| Q1 2025 | 258 | $4.58B |
| Q4 2024 | 191 | $3.19B |
| Q3 2024 | 150 | $1.95B |
| Q2 2024 | 125 | $957.0M |
| Q1 2024 | 113 | $1.08B |
| Q4 2023 | 117 | $1.35B |
| Q3 2023 | 102 | $1.07B |
| Q2 2023 | 105 | $1.33B |
| Q1 2023 | 95 | $1.21B |
| Q4 2022 | 88 | $1.31B |
| Q3 2022 | 68 | $529.0M |
| Q2 2022 | 40 | $145.9M |
| Q1 2022 | 39 | $181.7M |
| Q4 2021 | 42 | $248.0M |
| Q3 2021 | 40 | $202.7M |
| Q2 2021 | 37 | $239.9M |
| Q1 2021 | 37 | $305.1M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Verona Pharma plc; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wellington Management Group LLP | 4,303,303 | $91.0M | 0.02% | +1,011,830+30.7% | Added |
| Perceptive Advisors LLC | 4,397,116 | $93.0M | 2.70% | +1,663,326+60.8% | Added |
| NEA Management Company, LLC | 5,108,563 | $118.1M | 9.01% | −476,190−8.5% | Reduced |
| Ra Capital Management, L.P. | 6,317,990 | $133.6M | 2.52% | 00.0% | Unchanged |
| FMR LLC | 7,109,770 | $150.3M | 0.01% | +2,542,591+55.7% | Added |
| Resolute Capital Asset Partners LLC | 0 | $0 | 0.00% | −115,000−100.0% | Sold out |
| Artia Global Partners LP | 0 | $0 | 0.00% | −90,451−100.0% | Sold out |
| Altium Capital Management LP | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −14,364−100.0% | Sold out |
| Kapitalo Investimentos Ltda | 0 | $0 | 0.00% | −12,844−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −12,640−100.0% | Sold out |
| Stratos Wealth Partners, LTD. | 0 | $0 | 0.00% | −11,540−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −5,235−100.0% | Sold out |
| North Star Investment Management Corp. | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| Mirabella Financial Services LLP | 0 | $0 | 0.00% | −29,383−100.0% | Sold out |